| 17-May-13 01:04PM | CELSION CORP Financials EDGAR Online Financials +7.45% |
| 12:52PM | GM Initiates Cadillac Recall, InterOil Gets Offer For Elk Stake, and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 08:03AM | InPlay: Celsion's ThermoDox HEAT study findings reviewed at the 9th Annual World Conference on Interventional Oncology; Duration of RFA procedure correlates with an overall survival benefit Briefing.com |
| 08:00AM | Celsion's ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) PR Newswire |
| 15-May-13 09:54AM | Amarin & Celsion: Post-Earnings Roundup at Seeking Alpha |
| 09-May-13 01:23PM | Celsion's Q1 Call: What You Need To Know at Seeking Alpha -7.92% |
| 12:54PM | Celsion Corporation's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 10:11AM | Celsion: New Findings Show Act Of Desperation at Seeking Alpha |
| 08:32AM | InPlay: Celsion beats by $0.04 Briefing.com |
| 08:00AM | Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update PR Newswire |
| 07:07AM | Q1 2013 Celsion Corp Earnings Release - Before Market Open CCBN |
| 01:43AM | CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 03-May-13 10:18PM | Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential at Seeking Alpha |
| 01-May-13 01:16PM | Celsion's A Fighter at Seeking Alpha |
| 08:12AM | InPlay: Celsion announces thermoDox HEAT study findings to be reviewed at the 9th Annual World Conference on Interventional Oncology on May 16, 2013 Briefing.com |
| 08:00AM | Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013 PR Newswire |
| 08:00AM | Celsion Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013 PR Newswire |
| 26-Apr-13 07:00AM | The 5 Dumbest Things on Wall Street This Week TheStreet |
| 07:00AM | [video] 5 Dumbest Things on Wall Street at TheStreet |
| 25-Apr-13 08:00AM | 5 Dumbest Things on Wall Street TheStreet.com TV |
| 23-Apr-13 05:11PM | Celsion's Shameless Spin Job (Update) at TheStreet +14.29% |
| 11:51AM | Are We Watching Celsion Rise From The Grave? at Seeking Alpha |
| 09:38AM | Celsion's Shameless Spin Job at TheStreet |
| 08:13AM | Celsion conducts comprehensive analysis of data from Phase III Heat study theflyonthewall.com |
| 08:06AM | InPlay: Celsion Provides Business Update; HEAT study analysis shows ThermoDox improves progression free survival and overall survival when heating is optimized Briefing.com |
| 08:05AM | BRIEF-Celsion up in premarket trading after comments at Reuters |
| 08:00AM | Celsion Corporation Provides Business Update PR Newswire |
| 11-Apr-13 05:55AM | BSD Medical News To Create A Spark at Seeking Alpha |
| 09-Apr-13 09:33AM | 3 Biotechs And The Feuerstein-Ratain Rule at Seeking Alpha |
| 23-Mar-13 07:15AM | A Fool Looks Back at Motley Fool |
| 22-Mar-13 09:15AM | Celsion Corp Director Buys 20K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet |
| 07:00AM | Why This Fund Manager Is Short Ziopharm at TheStreet |
| 21-Mar-13 01:04PM | CELSION CORP Financials EDGAR Online Financials |
| 18-Mar-13 02:56PM | Celsion's ThermoDox May Be Back In Play at Seeking Alpha |
| 02:45PM | 5 Investing Tricks Of The Trade For Your Arsenal at Seeking Alpha |
| 01:40PM | Celsion Corporation's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 10:40AM | Monday movers: J.C. Penney outperforms S&P 500 at MarketWatch |
| 09:06AM | Mondays movers: Deutsche, BNP Paribas at MarketWatch |
| 09:05AM | InPlay: Celsion ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT Study; reports FY12 results Briefing.com |
| 08:00AM | Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update PR Newswire |
| 07:07AM | Q4 2012 Celsion Corp Earnings Release - Before Market Open CCBN |
| 01:29AM | CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 16-Mar-13 07:30AM | The Fool Looks Ahead at Motley Fool |
| 12-Mar-13 08:00AM | Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013 PR Newswire -6.96% |
| 10-Mar-13 08:34PM | 4 Biotech Stocks Looking To Heat Up In Time For Summer at Seeking Alpha |
| 07:06PM | Celsion Has Multi-Bagger Potential From Here at Seeking Alpha |
| 08-Mar-13 06:28AM | 4 Stocks Under $10 Spiking Higher at TheStreet |
| 06-Mar-13 01:57PM | 3 Biotech Stocks Ready To Rally at Seeking Alpha +5.10% |
| 05:28AM | Biotech Stocks With Recent Developments: 3 To Consider, 1 To Avoid at Seeking Alpha |
| 05-Mar-13 07:29PM | 2 Biotech Superstars For 2013 at Seeking Alpha |
| 28-Feb-13 09:46AM | A 2013 Diversified Bullish Portfolio In 10 Positions at Seeking Alpha |
| 26-Feb-13 09:26AM | CELSION CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Secur EDGAR Online |
| 06:17AM | Following Crashing Biotechs - 5 Bargains To Consider at Seeking Alpha |
| 22-Feb-13 01:44PM | Celsion Dilutes By Fifty Percent at Seeking Alpha |
| 09:30AM | CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements an EDGAR Online |
| 09:17AM | InPlay: Celsion receives commitments from institutional investors to purchase an aggregate of $15 mln of the co's securities in an at-the-market registered direct offering, led by a dedicated health care fund Briefing.com |
| 09:15AM | Celsion Corporation Announces $15 Million Registered Direct Offering PR Newswire |
| 21-Feb-13 08:25PM | A Biotech Winner For 2013 at Seeking Alpha |
| 20-Feb-13 01:49AM | The War Over Amarin : Feuerstein Battles Heisenberg And How I'd Invest It at Seeking Alpha -5.43% |
| 15-Feb-13 06:30AM | Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma at TheStreet |
| 13-Feb-13 03:23PM | 3 Events Biotech Investors Need to Watch in 2013 at Motley Fool -5.80% |
| 12-Feb-13 10:45AM | Should Sane Investors Consider Celsion? at Wall St. Cheat Sheet -10.39% |
| 09:34AM | After Phase III Failure, Celsion Is Still Worthless at Seeking Alpha |
| 08:27AM | Will Celsion Survive? at Seeking Alpha |
| 11-Feb-13 02:26PM | Are these Monday Movers Going Higher? at Motley Fool +19.38% |
| 10-Feb-13 02:55AM | China Biotech In Review: Cardinal Health Uses M&A To Add Drug Distribution Reach at Seeking Alpha |
| 08-Feb-13 01:55PM | 5 Stocks Showing Major Breakouts at TheStreet +11.21% |
| 07-Feb-13 03:57PM | Speculative Biotech Stocks That Could Bounce at Seeking Alpha |
| 06-Feb-13 06:05AM | CELSION CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statements a EDGAR Online |
| 05-Feb-13 06:31PM | InPlay: Celsion provides an update regarding ThermoDox agreements with Zhejiang HISUN Pharmaceutical Company for China: Zheijang does not plan to pursue exclusive option to license ThermoDox Briefing.com +5.13% |
| 06:30PM | Celsion Corporation Provides an Update Regarding ThermoDox® Agreements with Zhejiang HISUN Pharmaceutical Company for China PR Newswire |
| 06:37AM | Ziopharm's Sarcoma Study And The Feuerstein-Ratain Rule at TheStreet |
| 04-Feb-13 03:31PM | Small Pharmaceuticals With Near Term Catalysts - Durect And Inovio at Seeking Alpha -11.36% |
| 09:44AM | This Week in Biotech at Motley Fool |
| 09:36AM | Is Delcath The Post-Celsion Play On Liver Cancer? at Seeking Alpha |
| 02-Feb-13 09:54AM | Celsion Stock Blown Apart On Thermodox Phase III Data at Seeking Alpha |
| 01-Feb-13 06:02PM | Nasdaq stocks posting largest volume increases AP -12.58% |
| 05:34PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 01:18PM | Most active Nasdaq-traded stocks AP |
| 08:38AM | CELSION CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 08:20AM | Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High Marketwire |
| 08:15AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:00AM | Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta at TheStreet |
| 31-Jan-13 10:38PM | Celsion's 'Bad Beat' : 4 'Tells' That Longs Missed at Seeking Alpha -81.17% |
| 08:25PM | Why Celsion Shares Were Eviscerated at Motley Fool |
| 06:05PM | Nasdaq stocks posting largest volume increases AP |
| 06:05PM | Most active Nasdaq-traded stocks AP |
| 03:39PM | Celsion Phase III Failure: What Went Wrong? at Seeking Alpha |
| 03:21PM | Why Shares of Celsion Got Crushed Today at Motley Fool |
| 01:23PM | Celsion Shares Nosedive After Cancer Therapy Fails at Minyanville |
| 01:16PM | Most active Nasdaq-traded stocks AP |
| 11:45AM | Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against Celsion Corporation Business Wire |
| 11:36AM | Celsion plunges 80 percent as liver cancer therapy fails trial at Reuters |
| 11:31AM | Can Celsion Survive After Imploding Over Phase III Results? at Seeking Alpha |
| 10:13AM | Thursdays biggest gaining and declining stocks at MarketWatch |
| 10:01AM | Celsion Collapses on Failure: What's Next? at Motley Fool |
| 08:40AM | Thursdays biggest gaining and declining stocks at MarketWatch |
| 08:23AM | Facebook Slides in Flat U.S. Futures Market at The Wall Street Journal |
| 07:38AM | InPlay: Celsion trading down 84% on disappointing Phase III data on ThermoDox in Primary Liver Cancer; Study did not provide sufficient evidence of clinical effectiveness Briefing.com |
| 07:33AM | BRIEF-Celsion plunges after therapy fails to meet goal at Reuters |
